References
- Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118(8):2048-55
- Health Professionals. CervicalCheck: The National Healthcare Screening Programme. Available from: http://www.cervicalcheck.ie/health-professionals/about-the-programme.149.html [Last accessed 21 February 2012]
- Rebolj M, Helmerhorst T, Habbema D, et al. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ 2012;345:e6855
- Lanceley A, Fiander A, McCormack M, Bryant A. Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database Syst Rev 2013;11-CD008767
- Khalid S, Carcopino X, Michail G, et al. Compliance with follow up cytology after discharge from the colposcopy clinic. Ir Med J 2015;108:4
- Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health 2014;17(1):5-14
- Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132(5):1133-45
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France. 2012; Available from: http://globocan.iarc.fr. [ [Last accessed 28 January 2013]
- National Cancer Registry Ireland. Cancer Factsheet: Cervix. 2013. Available from: http://www.ncri.ie/sites/ncri/files/factsheets/FACTSHEET_cervix.pdf [Last accessed 12 January 2014]
- Kocken M, Uijterwaal MH, de Vries AL, et al. High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis. Gynecol Oncol 2012;125(2):500-7
- Health Information and Quality Authority. Report of the evaluation of the use of resources in the national population based cancer screening programmes and associated services. Cork: 2009. Available from: http://www.hiqa.ie/system/files/Colorectal_cancer_evaluation_report_HTA.pdf [Last accessed 15 May 2015]
- Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119(5):1095-101
- Katki HA, Wentzensen N. How might HPV testing be integrated into cervical screening? Lancet Oncol 2012;13(1):8-10
- Bulk S, Visser O, Rozendaal L, et al. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005;113(6):1005-9
- Vahidnia F, Hirschler NV, Agapova M, et al. Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study. J Cancer Epidemiol 2013;2013:814842
- Zielinski GD, Rozendaal L, Voorhorst FJ, et al. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 2003;91(1):67-73
- Arbyn M, Sasieni P, Meijer CJ, et al. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006;24(Suppl 3):S3/78-89
- Uijterwaal MH, Kocken M, Berkhof J, et al. Posttreatment assessment of women at risk of developing high-grade cervical disease: proposal for new guidelines based on data from the Netherlands. J Low Genit Tract Dis 2014;18(4):338-43
- Kocken M, Helmerhorst TJ, Berkhof J, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. The Lancet Oncology 2011;12(5):441-50
- Health information and quality authority. guidelines for the budget impact analysis of health technologies in Ireland. health information and quality authority. cork. 2010. Available from: http://www.hiqa.ie/publications/guidelines-budget-impact-analysis-health-technologies-ireland [Last accessed 15 May 2015]
- TreeAge Software Inc. TreeAge Pro 2009. (Ed.^(Eds) (Williamstown MA, 2009
- Cubie HA, Canham M, Moore C, et al. Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H). J Clin Pathol 2014;67(6):458-63
- Jordan J, Martin-Hirsch P, Arbyn M, et al. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology 2009;20(1):5-16
- Legood R, Smith M, Lew JB, et al. Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS sentinel sites study. Bmj 2012;345:e7086